Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

ClinicalTrials.gov ID: NCT03100942

Public ClinicalTrials.gov record NCT03100942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome

Study identification

NCT ID
NCT03100942
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
152 participants

Conditions and interventions

Interventions

  • Lanraplenib Drug
  • Filgotinib Drug
  • Tirabrutinib Drug
  • Lanraplenib placebo Drug
  • Filgotinib placebo Drug
  • Tirabrutinib placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2017
Primary completion
Jan 9, 2019
Completion
Oct 1, 2019
Last update posted
Oct 22, 2020

2017 – 2019

United States locations

U.S. sites
34
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
AARR Arizona Arthritis & Rheumatology Research Mesa Arizona 85202
AARR Arizona Arthritis & Rheumatology Research Phoenix Arizona 85032
Medvin Clinical Research Covina California 91723
Inland Rheumatology Clinical Trials, Inc. Upland California 91786
Denver Arthritis Clinic Denver Colorado 80230
Clinical Research of West Florida, Inc. Clearwater Florida 33765
Omega Research Consultants LLC DeBary Florida 32713
Center for Rheumatology Immunology and Arthritis Fort Lauderdale Florida 33309
Suncoast Clinical Research, Inc. New Port Richey Florida 34668
IRIS Research and Development, LLC Plantation Florida 33324
North Georgia Rheumatology Group, PC Lawrenceville Georgia 30046
Springfield Clinic Springfield Illinois 62703
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701
June DO, PC Lansing Michigan 48910
North Mississippi Medical Clinics, Inc. - Clinical Research Tupelo Mississippi 38801
Clayton Medical Associates St Louis Missouri 63117
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Albuquerque Clinical Trials Albuquerque New Mexico 87102
Joint and Muscle Research Institute Charlotte North Carolina 28204
Cape Fear Arthritis Care, PLLC Leland North Carolina 28451
PMG Research of Salisbury Salisbury North Carolina 28144
East Penn Rheumatology Associates, P.C. Bethlehem Pennsylvania 18015
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading, LLC Wyomissing Pennsylvania 19610
ClinSearch Chattanooga Tennessee 37421
Ramesh C. Gupta, MD Memphis Tennessee 38119
Diagnostic Group Integrated Healthcare System, Pllc Beaumont Texas 77701
Accurate Clinical Research Inc. Houston Texas 77034
Southwest Rheumatology Research Mesquite Texas 75150
Trinity Universal Research Associates Plano Texas 75024
Arthritis & Osteoporosis Clinic Waco Texas 76710
Wasatch Peak Family Practice Layton Utah 84041
The Center for Arthritis and Rheumatic Diseases, PC Chesapeake Virginia 23320
Arthritis Northwest Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03100942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 22, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03100942 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →